retatrutide heart issues Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Extreme Side Effects Followed Overdose

doi: 10.1111/j.1365-2958.2003.03947.x 239 PagliucaC.ColicchioR.RestaS

Multiple injections of the same drug in a single encounter are reported as additional units of 96372 with modifier 76 (same provider) or 77 (different provider) Multiple injections of different drugs at the same visit are reported as additional units with modifier 59 for each distinct drug/site The MUE of 3 means Medicare will not reimburse more than 3 injection administration units per provider per patient per day without additional documentation

Retatrutide is an investigational peptide drug currently under clinical development by Eli Lilly

Reputable providers are upfront about this

& Agrawal, V

A type of lipid that's the major (about 75%) component of all cell membranes